Gildan Q3 sales surge 61% to $1.47B, missing outlook
Gildan Activewear (NYSE:GIL) reported third-quarter 2026 sales of $1.47 billion, up 61.1% year over year following its HanesBrands acquisition, but below its approximately $1.65 billion forecast.
Gildan Activewear (NYSE:GIL) reported third-quarter 2026 sales of $1.47 billion, up 61.1% year over year following its HanesBrands acquisition, but below its approximately $1.65 billion forecast.
ConocoPhillips (NYSE:COP) reported third-quarter 2026 net income of $4 billion, or $3.34 per diluted share, while adjusted earnings reached $3.27 per share, exceeding analyst expectations.
Privia Health (NASDAQ:PRVA) reported third-quarter 2026 revenue of $657 million, up 13.2% year over year, while net income attributable to the company increased 96.6% to $13.5 million.
Air Products (NYSE:APD) reported fiscal 2026 adjusted earnings per share of $13.45, up 12% year over year, as annual sales increased 8% to approximately $13 billion.
Cardinal Health (NYSE:CAH) reported first-quarter fiscal 2027 revenue of $67.5 billion, up 5% year over year, while non-GAAP diluted earnings per share increased 28% to $3.26.
Celsius Holdings (NASDAQ:CELH) reported record third-quarter 2026 revenue of $847.2 million, up 16.8% from $725.1 million a year earlier, beating analyst revenue expectations of approximately $800 million.
Kimberly-Clark (NASDAQ:KMB) reported third-quarter 2026 financial results, with preliminary net sales estimated at $4.134 billion, compared with $4.150 billion in the same period of 2025.
The Cigna Group (NYSE:CI) reported third-quarter 2026 revenue of $73.7 billion, up 6% year over year, and raised its full-year adjusted earnings forecast to at least $30.60 per share.
Primo Brands (NYSE:PRMB) reported third-quarter 2026 net sales of $1.821 billion, up 3.1% year over year, while net income from continuing operations increased to $124.5 million from $40.5 million.
Arhaus (NASDAQ:ARHS) reported third-quarter 2026 revenue of $368 million, up 6.8% year over year, while net income declined 36% to $8 million from the prior-year period.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy